Yahoo! Finance: ANX News

ADVENTRX Pharmaceuticals to Present at the OneMedForum Finance Conference on January 13 (PR Newswire)

Wed, 6 Jan 2010 13:00:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the OneMedForum Finance Conference on Wednesday, January 13, 2010, at 4:30 p.m.

J.P. Morgan Healthcare Confab: Preview (at TheStreet.com)

Tue, 5 Jan 2010 11:00:00 Etc/GMT

ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)

Mon, 4 Jan 2010 14:23:27 Etc/GMT

ADVENTRX Pharmaceuticals Announces Financing (PR Newswire)

Mon, 4 Jan 2010 14:15:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. announced today that it has signed agreements to purchase shares of its Series E convertible preferred stock pursuant to a registered direct offering to institutional investors, representing gross proceeds to ADVENTRX of approximately $19,000,000. Â ADVENTRX plans to use the net proceeds from the offering to fund activities relating to the commercial launch of ANX-530, including acquiring or developing sales, marketing and distribution capabilities and the associated regulatory compliance infrastructure, and to continue the development of ANX-514 in the United States, and for general corporate purposes.

ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application (PR Newswire)

Mon, 4 Jan 2010 11:00:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application to the U.S. Food and Drug Administration for its product candidate ANX-530 .

It's Time for Adventrx to Follow Through on NDA (at Seeking Alpha)

Wed, 30 Dec 2009 14:42:03 Etc/GMT

Adventrx Pharmaceuticals Gains Nearly 63%, Still Looking for More (at Seeking Alpha)

Tue, 29 Dec 2009 09:58:03 Etc/GMT

Beware Gold's Rally (TheStreet.com TV)

Mon, 28 Dec 2009 14:52:48 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/26/59/92.jpg/yfinance/tscm/strategysession/10652634http://www.thestreet.com/

ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and (EDGAR Online)

Thu, 24 Dec 2009 17:52:56 Etc/GMT

[video] Beware Gold's Rally (at TheStreet.com)

Thu, 24 Dec 2009 16:53:49 Etc/GMT

Emerging Stock Report Initiates Independent Research Coverage on ADVENTRX Pharmaceuticals, Inc. (GlobeNewswire)

Thu, 17 Dec 2009 16:22:49 Etc/GMT

CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on ADVENTRX Pharmaceuticals, Inc. . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.

ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference (PR Newswire)

Wed, 9 Dec 2009 13:00:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences On-line Forum on December 15, 2009 at 9:30 a.m.

Stock Watch: StockPreacher.com Issues Market Alert for ADVENTRX Pharmaceuticals Inc. (GlobeNewswire)

Fri, 4 Dec 2009 12:30:00 Etc/GMT

DALLAS -- StockPreacher.com announces an investment report featuring ADVENTRX Pharmaceuticals Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

Emerging Stock Report Initiates Independent Research Coverage On ADVENTRX Pharmaceuticals, Inc. (GlobeNewswire)

Tue, 1 Dec 2009 16:19:32 Etc/GMT

ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 (PR Newswire)

Tue, 1 Dec 2009 13:00:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. today announced that a new, recently completed preclinical study has affirmed the bioequivalence and comparable toxicity of ANX-514 and Taxotere® .

[video] $5 Gold Stocks (at TheStreet.com)

Wed, 25 Nov 2009 13:00:02 Etc/GMT

ADVENTRX PHARMACEUTICALS INC Financials (EDGAR Online Financials)

Tue, 17 Nov 2009 14:04:27 Etc/GMT

ADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)

Tue, 10 Nov 2009 21:30:00 Etc/GMT

ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results (PR Newswire)

Tue, 10 Nov 2009 21:05:00 Etc/GMT

ADVENTRX Pharmaceuticals, Inc. today reported financial results for the three and nine months ended September 30, 2009.

Trading Review for Adventrx Pharmaceuticals Inc. Issued by Beacon Equity (GlobeNewswire)

Fri, 23 Oct 2009 10:50:00 Etc/GMT

DALLAS -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Adventrx Pharmaceuticals Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.